Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Government of Canada was posted on May 24, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Systematic Review/Evidence Synthesis

Closed
1000249797Canada

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Government of Canada → Jeremy MallonView Agency

NAICS

N/A

Place of Performance

CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Jeremy Mallon
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → Jeremy Mallon
View Agency Profile
Office AddressN/A
Contacts
Jeremy MallonPoint of Contact

Full Description

Show more
Technical support relating to evidence synthesis reviews and methods training and support to support the recommendation development process of the National Advisory Committee on Immunization, 2024/5. The objective is to obtain the professional services of one or more Contractors on an “as and when required” basis to conduct evidence synthesis reviews, specific technical requests related to evidence synthesis, and potentially methods training or support. The initial period of contract is from the date of contract award to March 31, 2025 plus up to two (2) additional one (1) year option periods under the same conditions.